Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

The FDA has approved a new muscarinic receptor antagonist for the treatment of overactive bladder.

Pharmacology Update: Fesoterodine Fumarate Extended Release Tablets (Toviaz™)